Big blow: India revokes GSK cancer drug patent

India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that......

Stocks of MNCs with high promoter stake lose steam

Stock investors are turning averse to one of the most popular investment themes on Dalal Street in the past year or so. The recent rally in the shares of multinational companies (MNCs) with......

AstraZeneca India to delist scrip

AstraZeneca Pharma India, the Indian subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, has decided to delist its scrip from the Bombay Stock Exchange, National Stock Exchange and Bangalore......